IDiyas

For the Inventor, By the Inventor

Boston, MA, United States of America

Kathryn Phillips

USPTO Granted Patents = 12

Average Co-Inventor Count = 5.5

ph-index = 5

Forward Citations = 181(Granted Patents)


Location History:

  • Marlborough, MA (US) (1999 - 2010)
  • Boston, MA (US) (2003 - 2012)

Company Filing History:

goldMedal8 out of 43 
 
Praecis Pharmaceuticals, Inc.
 patents
silverMedal4 out of 1,325 
 
Yale University
 patents

Years Active: 1999-2012

Loading Chart...
12 patents (USPTO):Explore Patents
1. 8242240 - Anti-inflammatory compounds and uses thereof (2012-08-14),
2. 7812118 - Anti-inflammatory compounds and uses thereof (2010-10-12),
3. 7803774 - Modulators of β-amyloid peptide aggregation (2010-09-28),
4. 7534858 - Anti-inflammatory compounds and uses thereof (2009-05-19),
5. 7175828 - Modulators of β-amyloid peptide aggregation comprising D-amino acids (2007-02-13),
6. 7049395 - Anti-inflammatory compounds and uses thereof (2006-05-23),
7. 6831066 - Modulators of &bgr;-amyloid peptide aggregation (2004-12-14),
8. 6689752 - Modulators of &bgr;-amyloid peptide aggregation comprising D-amino acids (2004-02-10),
9. 6610658 - Modulators of &mgr;-amyloid peptide aggregation (2003-08-26),
10. 6303567 - Modulators of &bgr;-amyloid peptide aggregation comprising D-amino acids (2001-10-16),
11. 6277826 - Modulators of &bgr;-amyloid peptide aggregation comprising D-amino acids (2001-08-21),
12. 5985242 - Modulators of .beta.-amyloid peptide aggregation comprising D-amino acids (1999-11-16),

Title: Kathryn Phillips: Innovator in Anti-Inflammatory Compounds

Introduction

Kathryn Phillips is a prominent inventor based in Boston, MA, known for her significant contributions to the field of pharmaceuticals. With a total of 12 patents to her name, she has made remarkable strides in developing anti-inflammatory compounds that have the potential to transform treatment options for inflammatory disorders.

Latest Patents

Among her latest patents is a groundbreaking invention focused on anti-inflammatory compounds and their uses. This invention provides pharmaceutical compositions aimed at treating inflammatory disorders. Additionally, it outlines methods for identifying these anti-inflammatory compounds and inhibiting NF-κB-dependent target gene expression in cells. This innovative approach showcases her commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout her career, Kathryn has worked with esteemed organizations such as Praecis Pharmaceuticals, Inc. and Yale University. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to significant research initiatives.

Collaborations

Some of her notable coworkers include Mark A. Findeis and Malcolm L. Gefter, who have played a role in her research endeavors. Their collaboration has further enriched her work and expanded the impact of her inventions.

Conclusion

Kathryn Phillips stands out as an influential inventor in the pharmaceutical industry, particularly in the development of anti-inflammatory treatments. Her innovative patents and collaborations reflect her dedication to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…